Keyword Search
Legend:
CC = Baltimore Convention Center, H = Hilton Baltimore
* = applied session ! = JSM meeting theme
|
Keyword Search Criteria: Surrogate endpoint returned 8 record(s)
|
|
Monday, 07/31/2017
|
Response Biomarker Versus Surrogate Endpoints Validation: Evolution of Statistical Approaches
Sue-Jane Wang, FDA
8:35 AM
|
Surrogacy for Regulatory Approval: The Follicular Lymphoma Analysis of Surrogate Hypothesis (FLASH) Project
Qian Shi, Mayo Clinic
9:00 AM
|
The Surrogate Threshold Effect for Event-Free Survival as a Potential Surrogate for Overall Survival in Patients Treated for Acute Myeloid Leukemia
Marc Buyse, IDDI Inc.; Richard Schlenk, University Hospital of Ulm, Germany; Hartmund Dohner, University Hospital of Ulm, Germany; Tomasz Burzykowski, IDDI S.A.
9:25 AM
|
Issues Related to Statistical Validation of Minimal Residual Disease as a Surrogate Endpoint for Clinical Trials and Drug Approvals in AML
Liang Xiu, Janssen Research and Development; Rianka Bhattacharya, Janssen Research and Development; Jianan Hui, University of California, Riverside; Hong Tian, Janssen Research and Development
9:50 AM
|
|
|
